Diagnosis is made by demonstrating delayed gastric emptying in a symptomatic patient after excluding other potential causes of the symptoms.[1]Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol. 2022 Aug 1;117(8):1197-220.
https://journals.lww.com/ajg/Fulltext/2022/08000/ACG_Clinical_Guideline__Gastroparesis.15.aspx
http://www.ncbi.nlm.nih.gov/pubmed/35926490?tool=bestpractice.com
The symptoms are nonspecific and can mimic other disorders, such as ulcer disease, partial gastric or small-bowel obstruction, gastric cancer, or pancreatobiliary disorders.[47]Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004 Nov;127(5):1592-622.
https://www.gastrojournal.org/article/S0016-5085(04)01634-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/15521026?tool=bestpractice.com
Clinicians should also recognize that gastroparesis could be a presenting symptom of a generalized gastrointestinal motility disorder.
History
Symptoms described by the patient that are suggestive of gastroparesis include early satiety, postprandial fullness, nausea, vomiting, bloating, and upper abdominal pain.[1]Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol. 2022 Aug 1;117(8):1197-220.
https://journals.lww.com/ajg/Fulltext/2022/08000/ACG_Clinical_Guideline__Gastroparesis.15.aspx
http://www.ncbi.nlm.nih.gov/pubmed/35926490?tool=bestpractice.com
A possible cause may become apparent from the clinical history: for example, the patient is known to have diabetes mellitus, multiple sclerosis, or scleroderma, or they have had previous abdominal surgery for other pathology. Reviewing the patient's drug list is recommended and, if practical, any drugs that might exacerbate gastroparesis or prevent the beneficial actions of a prokinetic agent should be removed (e.g., opioids, anticholinergics, tricyclic antidepressants, proton-pump inhibitors, interferon alfa, glucagon, calcitonin, octreotide, alcohol).[47]Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004 Nov;127(5):1592-622.
https://www.gastrojournal.org/article/S0016-5085(04)01634-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/15521026?tool=bestpractice.com
About 80% of patients with gastroparesis are female.[20]Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998 Nov;43(11):2398-404.
http://www.ncbi.nlm.nih.gov/pubmed/9824125?tool=bestpractice.com
Physical examination
There are no characteristic findings of gastroparesis on physical examination, but occasionally a succussion splash might be heard.[58]Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol. 2006 May;101(5):1129-39.
http://www.ncbi.nlm.nih.gov/pubmed/16696789?tool=bestpractice.com
This sign can be elicited by auscultating over the epigastrium while moving the patient from side to side or rapidly palpating the epigastrium. It indicates excessive fluid in the stomach from delayed gastric emptying or mechanical outlet obstruction.[47]Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004 Nov;127(5):1592-622.
https://www.gastrojournal.org/article/S0016-5085(04)01634-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/15521026?tool=bestpractice.com
Initial investigations
The following tests are recommended initially:[2]Lacy BE, Tack J, Gyawali CP. AGA clinical practice update on management of medically refractory gastroparesis: expert review. Clin Gastroenterol Hepatol. 2022 Mar;20(3):491-500.
https://www.cghjournal.org/article/S1542-3565(21)01151-4/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/34757197?tool=bestpractice.com
[47]Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004 Nov;127(5):1592-622.
https://www.gastrojournal.org/article/S0016-5085(04)01634-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/15521026?tool=bestpractice.com
Complete blood count
Metabolic profile including serum glucose, potassium, creatinine, liver function, total protein, and albumin
Serum amylase and lipase, to exclude acute pancreatitis if abdominal pain is significant
Thyroid-stimulating hormone, if hypothyroidism is a concern
HbA1c (to check for new diabetes and to assess glycemic control in patients with previously diagnosed diabetes)
Pregnancy test, if appropriate
Abdominal x-ray.
A cause for the symptoms may become apparent after these initial tests, such as pancreatitis or small bowel obstruction, in which case appropriate management is started.
Evaluation of organic disorders
Patients should then have esophagogastroduodenoscopy (EGD) to exclude mechanical gastric outlet obstruction, causes of which include pyloric stenosis, neoplasia, and active ulcer disease in the duodenum, pyloric channel, or prepyloric antrum. If no cause of obstruction is found and retained food is present in the stomach after an overnight fast, this may suggest gastroparesis. However, it should be noted that retained gastric food is frequently identified during EGD and should not in itself be deemed diagnostic of gastroparesis. Opioids, cardiovascular drugs, and acid suppressants have all been associated with retained gastric food.[1]Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol. 2022 Aug 1;117(8):1197-220.
https://journals.lww.com/ajg/Fulltext/2022/08000/ACG_Clinical_Guideline__Gastroparesis.15.aspx
http://www.ncbi.nlm.nih.gov/pubmed/35926490?tool=bestpractice.com
Routine EGD, with or without biopsy sampling, is well established as a safe and effective procedure. Although several adverse events are associated with routine EGD, their overall incidence is low.[59]Coelho-Prabhu N, Forbes N, Thosani NC, et al; ASGE Standards of Practice Committee. Adverse events associated with EGD and EGD-related techniques. Gastrointest Endosc. 2022 Sep;96(3):389-401.e1.
https://www.giejournal.org/article/S0016-5107(22)00337-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/35843754?tool=bestpractice.com
If the patient has symptoms suggestive of small bowel pathology, such as profound distension, steatorrhea or feculent emesis, or dilated small bowel loops on plain abdominal radiograph, then it is more appropriate to order contrast radiography at this stage, as this will demonstrate small bowel pathology better.
Evaluation for delayed gastric emptying
Gastric emptying scintigraphy demonstrating the emptying of a solid-phase meal is the definitive test for the diagnosis of gastroparesis because it quantifies the emptying of a physiologic meal.[60]American Diabetes Association Professional Practice Committee. 12. retinopathy, neuropathy, and foot care: standards of care in diabetes-2025. Diabetes Care. 2025 Jan 1;48(suppl 1):S252-65.
https://diabetesjournals.org/care/article/48/Supplement_1/S252/157552/12-Retinopathy-Neuropathy-and-Foot-Care-Standards
http://www.ncbi.nlm.nih.gov/pubmed/39651973?tool=bestpractice.com
Patients fast overnight and consume the freshly prepared radionuclide meal (250 kcal, low fat) in the morning within 20 minutes. Anterior and posterior scintigraphic images of the stomach are then obtained within 1 minute of completion of the meal (defined as 0) and at 60, 120, 180, and 240 minutes. A shorter version of the scintigraphy test that employs detailed imaging for 90 minutes and mathematical extrapolation of half-life for the diagnosis of gastroparesis should not be used as it often produces erroneous results.[47]Parkman, HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004 Nov;127(5):1592-622.
https://www.gastrojournal.org/article/S0016-5085(04)01634-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/15521026?tool=bestpractice.com
[61]Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000 Jun;95(6):1456-62.
http://www.ncbi.nlm.nih.gov/pubmed/10894578?tool=bestpractice.com
It is highly recommended that a 4-hour test be performed: retention of >10% of the test meal at the end of 4 hours, or >60% retention after 2 hours, supports a diagnosis of gastroparesis.[62]Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008 Mar;103(3):753-63.
https://deepblue.lib.umich.edu/handle/2027.42/72757
http://www.ncbi.nlm.nih.gov/pubmed/18028513?tool=bestpractice.com
Drugs that could impact on gastric emptying should be stopped for 48 hours before the test.[1]Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol. 2022 Aug 1;117(8):1197-220.
https://journals.lww.com/ajg/Fulltext/2022/08000/ACG_Clinical_Guideline__Gastroparesis.15.aspx
http://www.ncbi.nlm.nih.gov/pubmed/35926490?tool=bestpractice.com
A stable-isotope gastric emptying breath test (GEBT) is an alternative test for the diagnosis of gastroparesis. A standardized meal is given containing carbon-13 (C-13)-labeled spirulina. A minimum of five samples are required, and as the C-13 isotope is stable these can be collected with simple equipment in the office or at the bedside. Breath samples are collected at baseline and over a 4-hour period and sent for analysis. A half-life of 79 minutes or more is considered abnormal.[63]Bharucha AE, Camilleri M, Veil E, et al. Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol Motil. 2013 Jan;25(1):e60-9.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843948
http://www.ncbi.nlm.nih.gov/pubmed/23216872?tool=bestpractice.com
Wireless motility capsule (WMC) is a noninvasive ambulatory test that measures transit times and pressure parameters throughout the gastrointestinal tract. It is a one-time use, nondigestible, portable, small capsule that, when swallowed, records and transmits data to a receiver as it travels through the gut. The capsule can measure pH, pressure, and temperature to track location, gastric contents, and expulsion time from the different regions of the bowel. It has been approved by the Food and Drug Administration (FDA) for measuring gastric transit.[1]Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol. 2022 Aug 1;117(8):1197-220.
https://journals.lww.com/ajg/Fulltext/2022/08000/ACG_Clinical_Guideline__Gastroparesis.15.aspx
http://www.ncbi.nlm.nih.gov/pubmed/35926490?tool=bestpractice.com
The patient takes the capsule after eating a standardized meal and wears a small monitor that allows the telemetry recordings to be made. Gastric emptying time is assessed from ingestion of the capsule, a point at which there is a low pH reading, to the moment where there is an abrupt rise in pH after it moves into the small bowel.[64]Rao SS, Camilleri M, Hasler WL, et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011 Jan;23(1):8-23.
https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2010.01612.x
http://www.ncbi.nlm.nih.gov/pubmed/21138500?tool=bestpractice.com
A gastric emptying time of >5 hours compares favorably with gastric emptying scintigraphy for the diagnosis of gastroparesis.[65]Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008 Jan 15;27(2):186-96.
https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2007.03564.x
http://www.ncbi.nlm.nih.gov/pubmed/17973643?tool=bestpractice.com
WMC can also identify delays in small bowel and colonic transit, thus providing an opportunity to evaluate motor function throughout the entire gastrointestinal tract, which may be indicated in patients with gastrointestinal symptoms.[1]Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol. 2022 Aug 1;117(8):1197-220.
https://journals.lww.com/ajg/Fulltext/2022/08000/ACG_Clinical_Guideline__Gastroparesis.15.aspx
http://www.ncbi.nlm.nih.gov/pubmed/35926490?tool=bestpractice.com
[66]Lee AA, Rao S, Nguyen LA, et al. Validation of diagnostic and performance characteristics of the wireless motility capsule in patients with suspected gastroparesis. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1770-9.e2.
https://www.cghjournal.org/article/S1542-3565(18)31381-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/30557741?tool=bestpractice.com
If a diagnosis of gastroparesis is made, further tests are carried out to find a possible cause. The tests ordered are guided by the history and physical exam findings. A diagnosis of idiopathic gastroparesis is made only once all other causes have been excluded.
Emerging tests
Electrogastrography (EGG) is a noninvasive technique for recording gastric myoelectrical activity using cutaneous electrodes placed on the abdominal skin over the stomach. Studies suggest a complementary role of spatial mapping EGG for identification of the pathophysiologic mechanism of gastric function.[67]Carson DA, O'Grady G, Du P, et al. Body surface mapping of the stomach: new directions for clinically evaluating gastric electrical activity. Neurogastroenterol Motil. 2021 Mar;33(3):e14048.
http://www.ncbi.nlm.nih.gov/pubmed/33274564?tool=bestpractice.com
However, at this time, it is unclear if the information is clinically meaningful. Ongoing research of high-resolution EGG is needed to help clarify its clinical role.[1]Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol. 2022 Aug 1;117(8):1197-220.
https://journals.lww.com/ajg/Fulltext/2022/08000/ACG_Clinical_Guideline__Gastroparesis.15.aspx
http://www.ncbi.nlm.nih.gov/pubmed/35926490?tool=bestpractice.com